help button home button Am J Pathol Epitomics, Inc.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tateno, C.
Right arrow Articles by Yoshizato, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tateno, C.
Right arrow Articles by Yoshizato, K.
(American Journal of Pathology. 2004;165:901-912.)
© 2004 American Society for Investigative Pathology

Near Completely Humanized Liver in Mice Shows Human-Type Metabolic Responses to Drugs

Chise Tateno*{dagger}, Yasumi Yoshizane*{dagger}{ddagger}, Naomi Saito{dagger}, Miho Kataoka*{dagger}, Rie Utoh*, Chihiro Yamasaki*{dagger}, Asato Tachibana*{ddagger}, Yoshinori Soeno*§, Kinji Asahina{dagger}, Hiroshi Hino{dagger}, Toshimasa Asahara, Tsuyoshi Yokoi||, Toshinori Furukawa** and Katsutoshi Yoshizato*{dagger}{dagger}{dagger}

From the Yoshizato Project,* Cooperative Link of Unique Science and Technology for Economy Revitalization (CLUSTER), and Hiroshima Tissue Regeneration Project,{dagger} Collaboration of Regional Entities for the Advancement of Technological Excellence (CREATE), Japan Science and Technology Agency (JST), Prefectural Institute of Industrial Science and Technology; PhoenixBio Company, Limited{ddagger}; Life Science Research Laboratory,§ Chugai Technos Company, Limited; the Department of Biological Science,{dagger}{dagger} Developmental Biology Laboratory, Graduate School of Science, Hiroshima University, Higashihiroshima, Hiroshima; the Department of Surgery, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences; Research Facilities for Laboratory Animal Science,** School of Medicine, Hiroshima University, Hiroshima, Hiroshima; and the Division of Drug Metabolism,|| Faculty of Pharmaceutical Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan

Human hepatocytes were transplanted into urokinase-type plasminogen activator-transgenic SCID mice (uPA/SCID mice), which are immunodeficient and undergo liver failure. The transplanted cells were characterized in terms of their in vivo growth potential and functions. The human hepatocytes progressively repopulated the murine host liver. However, the recipients died when the replacement index (RI) of the human hepatocytes exceeded 50%. The hosts (chimeric mice) survived at RI >50% when treated with a drug that has anti-human complement factor activity, and these mice developed livers with RI values as high as 96%. In total, 36 chimeric mice were generated, and the rate of successful engraftment was as high as 92%. The yield of chimeric mice with RI >70% was 32%. The human hepatocytes in the murine host liver expressed mRNAs for a variety of human cytochrome P450 (hCYP) subtypes, in a manner that was similar to the donor liver. The mRNAs for hCYP3A4 and hCYP1A1/2 were induced in the liver in a CYP type-specific manner when the mice were treated with rifampicin and 3-methylcholanthrene, respectively. These results indicate that human hepatocytes that propagate in mice retain their normal pharmacological responses. We conclude that the chimeric mouse developed in the present study is a useful model for assessing the functions and pharmacological responses of human hepatocytes.





This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
L. Lootens, P. Van Eenoo, P. Meuleman, G. Leroux-Roels, and F. T. Delbeke
The uPA(+/+)-SCID Mouse with Humanized Liver as a Model for in Vivo Metabolism of 4-Androstene-3,17-dione
Drug Metab. Dispos., December 1, 2009; 37(12): 2367 - 2374.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
F. Botre
Humanized Animal Models to Study Drug Metabolism: No Longer a "Chimera"?
Clin. Chem., October 1, 2009; 55(10): 1763 - 1764.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
L. Lootens, P. Meuleman, O. J. Pozo, P. Van Eenoo, G. Leroux-Roels, and F. T. Delbeke
uPA+/+-SCID Mouse with Humanized Liver as a Model for In Vivo Metabolism of Exogenous Steroids: Methandienone as a Case Study
Clin. Chem., October 1, 2009; 55(10): 1783 - 1793.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
V. Chu, H. J. Einolf, R. Evers, G. Kumar, D. Moore, S. Ripp, J. Silva, V. Sinha, M. Sinz, and A. Skerjanec
In Vitro and in Vivo Induction of Cytochrome P450: A Survey of the Current Practices and Recommendations: A Pharmaceutical Research and Manufacturers of America Perspective
Drug Metab. Dispos., July 1, 2009; 37(7): 1339 - 1354.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
T. Inoue, K. Nitta, K. Sugihara, T. Horie, S. Kitamura, and S. Ohta
CYP2C9-Catalyzed Metabolism of S-Warfarin to 7-Hydroxywarfarin in Vivo and in Vitro in Chimeric Mice with Humanized Liver
Drug Metab. Dispos., December 1, 2008; 36(12): 2429 - 2433.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. Cheung and F. J. Gonzalez
Humanized Mouse Lines and Their Application for Prediction of Human Drug Metabolism and Toxicological Risk Assessment
J. Pharmacol. Exp. Ther., November 1, 2008; 327(2): 288 - 299.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
K. Okada, J. Shoda, K. Taguchi, J. M. Maher, K. Ishizaki, Y. Inoue, M. Ohtsuki, N. Goto, K. Takeda, H. Utsunomiya, et al.
Ursodeoxycholic acid stimulates Nrf2-mediated hepatocellular transport, detoxification, and antioxidative stress systems in mice
Am J Physiol Gastrointest Liver Physiol, October 1, 2008; 295(4): G735 - G747.
[Abstract] [Full Text] [PDF]


Home page
DMMHome page
N. Brezillon, D. Kremsdorf, and M. C. Weiss
Cell therapy for the diseased liver: from stem cell biology to novel models for hepatotropic human pathogens
Dis. Model. Mech., September 1, 2008; 1(2-3): 113 - 130.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
T. Kimura, M. Imamura, N. Hiraga, T. Hatakeyama, D. Miki, C. Noguchi, N. Mori, M. Tsuge, S. Takahashi, Y. Fujimoto, et al.
Establishment of an infectious genotype 1b hepatitis C virus clone in human hepatocyte chimeric mice
J. Gen. Virol., September 1, 2008; 89(9): 2108 - 2113.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
S. Kitamura, K. Nitta, Y. Tayama, C. Tanoue, K. Sugihara, T. Inoue, T. Horie, and S. Ohta
Aldehyde Oxidase-Catalyzed Metabolism of N1-Methylnicotinamide in Vivo and in Vitro in Chimeric Mice with Humanized Liver
Drug Metab. Dispos., July 1, 2008; 36(7): 1202 - 1205.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
Y. Sato, H. Yamada, K. Iwasaki, C. Tateno, T. Yokoi, K. Yoshizato, and I. Horii
Human Hepatocytes Can Repopulate Mouse Liver: Histopathology of the Liver in Human Hepatocyte-Transplanted Chimeric Mice and Toxicologic Responses to Acetaminophen
Toxicol Pathol, June 1, 2008; 36(4): 581 - 591.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K.-D. Bissig, T. T. Le, N.-B. Woods, and I. M. Verma
Repopulation of adult and neonatal mice with human hepatocytes: A chimeric animal model
PNAS, December 18, 2007; 104(51): 20507 - 20511.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
N. Masumoto, C. Tateno, A. Tachibana, R. Utoh, Y. Morikawa, T. Shimada, H. Momisako, T. Itamoto, T. Asahara, and K. Yoshizato
GH enhances proliferation of human hepatocytes grafted into immunodeficient mice with damaged liver
J. Endocrinol., September 1, 2007; 194(3): 529 - 537.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
H. Okumura, M. Katoh, T. Sawada, M. Nakajima, Y. Soeno, H. Yabuuchi, T. Ikeda, C. Tateno, K. Yoshizato, and T. Yokoi
Humanization of Excretory Pathway in Chimeric Mice with Humanized Liver
Toxicol. Sci., June 1, 2007; 97(2): 533 - 538.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
K. Okada, J. Shoda, M. Kano, S. Suzuki, N. Ohtake, M. Yamamoto, H. Takahashi, H. Utsunomiya, K. Oda, K. Sato, et al.
Inchinkoto, a herbal medicine, and its ingredients dually exert Mrp2/MRP2-mediated choleresis and Nrf2-mediated antioxidative action in rat livers
Am J Physiol Gastrointest Liver Physiol, May 1, 2007; 292(5): G1450 - G1463.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
H. Yatsuji, C. Noguchi, N. Hiraga, N. Mori, M. Tsuge, M. Imamura, S. Takahashi, E. Iwao, Y. Fujimoto, H. Ochi, et al.
Emergence of a Novel Lamivudine-Resistant Hepatitis B Virus Variant with a Substitution Outside the YMDD Motif
Antimicrob. Agents Chemother., November 1, 2006; 50(11): 3867 - 3874.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
D. W. Nebert
Comparison of gene expression in cell culture to that in the intact animal: relevance to drugs and environmental toxicants. Focus on "Development of a transactivator in hepatoma cells that allows expression of phase I, phase II, and chemical defense genes"
Am J Physiol Cell Physiol, January 1, 2006; 290(1): C37 - C41.
[Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
M. Katoh, T. Matsui, H. Okumura, M. Nakajima, M. Nishimura, S. Naito, C. Tateno, K. Yoshizato, and T. Yokoi
EXPRESSION OF HUMAN PHASE II ENZYMES IN CHIMERIC MICE WITH HUMANIZED LIVER
Drug Metab. Dispos., September 1, 2005; 33(9): 1333 - 1340.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
M. Katoh, T. Matsui, M. Nakajima, C. Tateno, Y. Soeno, T. Horie, K. Iwasaki, K. Yoshizato, and T. Yokoi
IN VIVO INDUCTION OF HUMAN CYTOCHROME P450 ENZYMES EXPRESSED IN CHIMERIC MICE WITH HUMANIZED LIVER
Drug Metab. Dispos., June 1, 2005; 33(6): 754 - 763.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
M. Katoh, T. Matsui, M. Nakajima, C. Tateno, M. Kataoka, Y. Soeno, T. Horie, K. Iwasaki, K. Yoshizato, and T. Yokoi
EXPRESSION OF HUMAN CYTOCHROMES P450 IN CHIMERIC MICE WITH HUMANIZED LIVER
Drug Metab. Dispos., December 1, 2004; 32(12): 1402 - 1410.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Society for Investigative Pathology.